Sector Chart Enanta Pharmaceuticals, Inc.

Equities

ENTA

US29251M1062

Market Closed - Nasdaq 04:00:00 2024-07-17 pm EDT 5-day change 1st Jan Change
15.82 USD -2.04% Intraday chart for Enanta Pharmaceuticals, Inc. +8.36% +68.12%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
342M - - -
47.96B -
42.45B
41.47B
31.6B -
28.63B